Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
McKesson
Express Scripts
Cipla
Fuji
AstraZeneca
Moodys
Teva
Accenture

Generated: February 17, 2019

DrugPatentWatch Database Preview

SOLIRIS Drug Profile

« Back to Dashboard

Summary for Tradename: SOLIRIS
Pharmacology for SOLIRIS
Mechanism of ActionComplement Inhibitors

US Patents for SOLIRIS

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16 ➤ Sign Up CureVac AG (Tubingen, DE) ➤ Sign Up RX Orphan search
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16 ➤ Sign Up Alexion Pharmaceuticals, Inc. (Cheshire, CT) ➤ Sign Up RX Orphan company
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16 ➤ Sign Up Janssen Pharmaceutica NV (Beerse, BE) ➤ Sign Up RX Orphan search
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16 ➤ Sign Up Aegis Therapeutics LLC (San Diego, CA) ➤ Sign Up RX Orphan search
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16 ➤ Sign Up Teva Pharmaceuticals Industries, Ltd. (Petach-Tikva, IL) ➤ Sign Up RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for SOLIRIS

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
SZ 12/2010 Austria ➤ Sign Up PRODUCT NAME: ECULIZUMAB
C00758904/01 Switzerland ➤ Sign Up FORMER REPRESENTATIVE: VOSSIUS AND PARTNER, CH
SPC/GB10/015 United Kingdom ➤ Sign Up PRODUCT NAME: ECULIZUMAB; REGISTERED: UK EU/1/07/393/001 20070620
10C0016 France ➤ Sign Up PRODUCT NAME: ECULIZUMAB; REGISTRATION NO/DATE: EU/1/07/393/001 20070620
C300433 Netherlands ➤ Sign Up PRODUCT NAME: ECULIZUMAB; REGISTRATION NO/DATE: EU/1/07/393/001 20070620
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Baxter
Citi
Fish and Richardson
Johnson and Johnson
Express Scripts
Harvard Business School
Boehringer Ingelheim
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.